- Previous Close
28.40 - Open
27.60 - Bid 28.00 x 33100
- Ask 28.50 x 32100
- Day's Range
27.60 - 27.60 - 52 Week Range
17.20 - 29.40 - Volume
1 - Avg. Volume
38 - Market Cap (intraday)
449.714M - Beta (5Y Monthly) 0.61
- PE Ratio (TTM)
12.21 - EPS (TTM)
2.26 - Earnings Date Jul 24, 2024 - Jul 29, 2024
- Forward Dividend & Yield 1.30 (4.51%)
- Ex-Dividend Date May 31, 2023
- 1y Target Est
--
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, and vías lagrimales treatments. The company is based in Madrid, Spain.
www.clinicabaviera.com1,254
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: D9Z.F
Performance Overview: D9Z.F
Trailing total returns as of 6/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: D9Z.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: D9Z.F
Valuation Measures
Market Cap
452.97M
Enterprise Value
439.07M
Trailing P/E
12.57
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.00
Price/Book (mrq)
4.49
Enterprise Value/Revenue
1.89
Enterprise Value/EBITDA
6.37
Financial Highlights
Profitability and Income Statement
Profit Margin
15.84%
Return on Assets (ttm)
19.03%
Return on Equity (ttm)
45.73%
Revenue (ttm)
227.07M
Net Income Avi to Common (ttm)
35.97M
Diluted EPS (ttm)
2.26
Balance Sheet and Cash Flow
Total Cash (mrq)
49.77M
Total Debt/Equity (mrq)
51.23%
Levered Free Cash Flow (ttm)
26.81M